News
AD/PD 2025: Further evidence for efficacy of TauRx’s LMTX, despite lack of true placebo comparator
If approved, LMTX has the potential to become the first orally available disease-modifying therapy (DMT) in the UK.
The leading Postpartum Depression Companies such as GH Research, Reunion Neuroscience, Lipocine, Brii Biosciences Limited, ...
Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released Novel DMT ...
5d
Condé Nast Traveler on MSNWhat to Expect from a Psychedelic Travel Experience, From Ayahuasca to PsilocybinUse precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Now, a photoswitchable DNA structure-specific, small-molecule ligand enables reversible, light-controlled regulation of gene expression and cell proliferation in live cells. Next generation ...
The use of oral and infusion disease-modifying therapies (DMT)… Smoking and obesity are both independently associated with faster disease progression in multiple sclerosis (MS), but when both ...
Institute of Chemistry, Analytical Chemistry for Health and Environment, University of Graz, Universitaetsplatz 1, Graz 8010, Austria Institute of Chemistry, ChromICP, University of Graz, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results